Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
ADALIMUMAB 40 MG/0.8ML SC PSKT (NDC 00074379902) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 30, 2026 , from http://ppman.hank.ai/transparency/procedure/00074379902/by-state?code_type=NDC
“ADALIMUMAB 40 MG/0.8ML SC PSKT (NDC 00074379902) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/00074379902/by-state?code_type=NDC. Accessed
October 30, 2026 .
“ADALIMUMAB 40 MG/0.8ML SC PSKT (NDC 00074379902) by State,” HANK Price Transparency ,
accessed October 30, 2026 ,
http://ppman.hank.ai/transparency/procedure/00074379902/by-state?code_type=NDC.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
NDC · across United States
00074379902 — Adalimumab 40 Mg/0.8ml Sc Pskt
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$6,583
National median
$5,307 – $7,054
IQR (p25 – p75)
5
hospitals filing
3
states
Walking in without insurance?
Cash / self-pay price
Cash median
$5,173
vs. negotiated
-21.4%
Hospitals reporting
5
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 00074379902 (NDC), with interquartile range
State Median p25 p75
CA $6,583 $5,340 $7,054
MI $5,731 $4,184 $6,756
NJ $5,280 $5,280 $9,644